Rankings
▼
Calendar
FTRE (Fortrea Holdings Inc.) Stock Financials & Earnings | Market Cap Arena
FTRE
Fortrea Holdings Inc.
Mkt Cap
$851M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$2.7B
Net Income (TTM)
-$986M
EPS (TTM)
-$10.97
Free Cash Flow (TTM)
$88M
Gross Margin
16.4%
Op. Margin
-19.8%
Net Margin
-36.2%
FCF Margin
3.2%
P/S Ratio (TTM)
0.3x
P/E Ratio (TTM)
—
YoY Rev Growth
+1.0%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$694M
$152M
$14M
Q2 23
$725M
$156M
$32M
Q3 23
$714M
$150M
$10M
Q4 23
$775M
$120M
-$11M
Q1 24
$662M
$108M
-$37M
Q2 24
$662M
$137M
-$51M
Q3 24
$675M
$148M
-$18M
Q4 24
$697M
$141M
-$56M
Q1 25
$651M
$117M
-$520M
Q2 25
$710M
$114M
-$11M
Q3 25
$701M
$103M
-$16M
Q4 25
$661M
$112M
$9M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
0.3x
5.1x
Q2 23
0.3x
6.5x
Q3 23
0.3x
15.2x
Q4 23
0.3x
—
Q1 24
0.3x
—
Q2 24
0.3x
—
Q3 24
0.3x
—
Q4 24
0.3x
—
Q1 25
0.3x
—
Q2 25
0.3x
—
Q3 25
0.3x
—
Q4 25
0.3x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$2M
-$18M
Q2 23
$150M
$141M
Q3 23
$2M
-$3M
Q4 23
$12M
$3M
Q1 24
-$26M
-$35M
Q2 24
$274M
$263M
Q3 24
-$2M
-$11M
Q4 24
$17M
$20M
Q1 25
-$124M
-$127M
Q2 25
$22M
$14M
Q3 25
$87M
$80M
Q4 25
$129M
$122M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$16M
Q2 23
$10M
Q3 23
$5M
Q4 23
$9M
Q1 24
$9M
Q2 24
$11M
Q3 24
$8M
Q4 24
$3M
Q1 25
$3M
Q2 25
$8M
Q3 25
$7M
Q4 25
$8M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-10.9%
-7.7%
Q2 23
-8.6%
-2.2%
Q3 23
-6.4%
+1.5%
Q4 23
+54.3%
+53.9%
Q1 24
-4.6%
+2.9%
Q2 24
-8.6%
+2.9%
Q3 24
-5.4%
-1.5%
Q4 24
-10.1%
-4.3%
Q1 25
-1.6%
+67.5%
Q2 25
+7.2%
+1.1%
Q3 25
+3.9%
+3.5%
Q4 25
-5.2%
-13.4%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$7M
1.0%
Q2 23
$9M
1.3%
Q3 23
$11M
1.6%
Q4 23
$16M
2.0%
Q1 24
$15M
2.3%
Q2 24
$15M
2.3%
Q3 24
$13M
1.9%
Q4 24
$0
0.0%
Q1 25
$15M
2.2%
Q2 25
$23M
3.2%
Q3 25
$22M
3.2%
Q4 25
$15M
2.2%
marketcaparena.com
OpEx Breakdown
SG&A
Quarter
SG&A
Q1 23
$117M
Q2 23
$98M
Q3 23
$107M
Q4 23
$99M
Q1 24
$120M
Q2 24
$156M
Q3 24
$136M
Q4 24
$148M
Q1 25
$122M
Q2 25
$125M
Q3 25
$107M
Q4 25
$103M
marketcaparena.com
Revenue Segments
Clinical Services Segment
Quarter
Clinical Services Segment
Q2 23
$726M
Q3 23
$712M
Q1 25
$651M
Q2 25
$710M
Q3 25
$701M
Q4 25
$661M
marketcaparena.com
Revenue by Geography
Europe
North America
Other Geographical Areas
Quarter
Europe
North America
Other Geographical Areas
Q1 24
$208M
$306M
$148M
Q2 24
$196M
$318M
$149M
Q3 24
$192M
$320M
$163M
Q1 25
$200M
$310M
$142M
Q2 25
$219M
$344M
$147M
Q3 25
$213M
$333M
$155M
Q4 25
$220M
$303M
$138M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$120M
$0
$120M
Q2 23
$114M
$0
$114M
Q3 23
$108M
$0
$108M
Q4 23
$109M
$0
$109M
Q1 24
$93M
$0
$93M
Q2 24
$126M
$0
$126M
Q3 24
$105M
$0
$105M
Q4 24
$119M
$0
$119M
Q1 25
$102M
$0
$102M
Q2 25
$81M
$0
$81M
Q3 25
$131M
$0
$131M
Q4 25
$175M
$0
$175M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
88M
+0.0%
Q2 23
89M
+0.5%
Q3 23
87M
-1.7%
Q4 23
88M
+0.5%
Q1 24
89M
+1.6%
Q2 24
89M
+0.2%
Q3 24
90M
+0.7%
Q4 24
90M
+0.0%
Q1 25
89M
-0.7%
Q2 25
91M
+1.3%
Q3 25
91M
+0.7%
Q4 25
91M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 20
—
—
FY 21
—
—
FY 22
—
—
FY 23
$158K
18K
FY 24
$174K
16K
FY 25
$190K
14K
marketcaparena.com